Evidence map›Paper›PMID 35021220›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Mapping the Cord Blood Transcriptome of Pregnancies Affected by Early Maternal Anemia to Identify Signatures of Fetal Programming.

Gad Hatem, Line Hjort, Olof Asplund, Daniel T R Minja, Omari Abdul Msemo, Sofie Lykke Møller, Thomas Lavstsen, Louise Groth-Grunnet, John P A Lusingu, Ola Hansson and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 4 countries.

Gad HatemGenomics, Diabetes and Endocrinology, Department of Clinical Sciences, Clinical Research Centre, Lund University Diabetes Centre, 205 02, Malmö, Sweden.
Line HjortDepartment of Obstetrics, Center for Pregnant Women with Diabetes, Rigshospitalet, 2100 Copenhagen, Denmark.
Olof AsplundGenomics, Diabetes and Endocrinology, Department of Clinical Sciences, Clinical Research Centre, Lund University Diabetes Centre, 205 02, Malmö, Sweden.
Daniel T R MinjaNational Institute for Medical Research, Tanga Center, 0255 Tanga, Tanzania.
Omari Abdul MsemoNational Institute for Medical Research, Tanga Center, 0255 Tanga, Tanzania.
Sofie Lykke MøllerSection of Global Health, Department of Public Health, University of Copenhagen, 1353 Copenhagen, Denmark.
Thomas LavstsenCenter for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
Louise Groth-GrunnetDepartment of Endocrinology (Diabetes and Bone-Metabolic Research Unit), 2100 Copenhagen, Denmark.
John P A LusinguNational Institute for Medical Research, Tanga Center, 0255 Tanga, Tanzania.
Ola HanssonGenomics, Diabetes and Endocrinology, Department of Clinical Sciences, Clinical Research Centre, Lund University Diabetes Centre, 205 02, Malmö, Sweden.
Dirk Lund ChristensenSection of Global Health, Department of Public Health, University of Copenhagen, 1353 Copenhagen, Denmark.
Allan A VaagSteno Diabetes Center Copenhagen, 2730 Gentofte, Denmark.
Isabella ArtnerGenomics, Diabetes and Endocrinology, Department of Clinical Sciences, Clinical Research Centre, Lund University Diabetes Centre, 205 02, Malmö, Sweden.
Thor TheanderCenter for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
Leif GroopGenomics, Diabetes and Endocrinology, Department of Clinical Sciences, Clinical Research Centre, Lund University Diabetes Centre, 205 02, Malmö, Sweden.ORCID 0000-0002-0187-3263
Christentze SchmiegelowCenter for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
Ib Christian BygbjergSection of Global Health, Department of Public Health, University of Copenhagen, 1353 Copenhagen, Denmark.
Rashmi B PrasadGenomics, Diabetes and Endocrinology, Department of Clinical Sciences, Clinical Research Centre, Lund University Diabetes Centre, 205 02, Malmö, Sweden.ORCID 0000-0002-4400-6741
University of Copenhagen · DKLund University · SENational Institute for Medical Research · TZSteno Diabetes Centers · DK

Funding

Danish Council for Strategic Research 1309-00003BLeif Groop, Diabetes Wellness Sverige 720-858-16JDWGLundbeck Foundation
6 · The paper itself

Abstract

contextAnemia during early pregnancy (EP) is common in developing countries and is associated with adverse health consequences for both mothers and children. Offspring of women with EP anemia often have low birth weight, which increases risk for cardiometabolic diseases, including type 2 diabetes (T2D), later in life.

objectiveWe aimed to elucidate mechanisms underlying developmental programming of adult cardiometabolic disease, including epigenetic and transcriptional alterations potentially detectable in umbilical cord blood (UCB) at time of birth.

methodsWe leveraged global transcriptome- and accompanying epigenome-wide changes in 48 UCB from newborns of EP anemic Tanzanian mothers and 50 controls to identify differentially expressed genes (DEGs) in UCB exposed to maternal EP anemia. DEGs were assessed for association with neonatal anthropometry and cord insulin levels. These genes were further studied in expression data from human fetal pancreas and adult islets to understand their role in beta-cell development and/or function.

resultsThe expression of 137 genes was altered in UCB of newborns exposed to maternal EP anemia. These putative signatures of fetal programming, which included the birth weight locus LCORL, were potentially mediated by epigenetic changes in 27 genes and associated with neonatal anthropometry. Among the DEGs were P2RX7, PIK3C2B, and NUMBL, which potentially influence beta-cell development. Insulin levels were lower in EP anemia-exposed UCB, supporting the notion of developmental programming of pancreatic beta-cell dysfunction and subsequently increased risk of T2D in offspring of mothers with EP anemia.

conclusionsOur data provide proof-of-concept on distinct transcriptional and epigenetic changes detectable in UCB from newborns exposed to maternal EP anemia.

Indexed as

AnemiaDiabetes Mellitus, Type 2AdultChildFemaleFetal BloodFetal DevelopmentHumansInfant, NewbornInsulinPregnancyTranscriptomeInsulinbeta-cell developmentbeta-cell functiondevelopmental programmingepigenetic programmingmaternal early pregnancy anemiatype 2 diabetes

Identifiers

PMID35021220
PMCPMC9016468
OpenAlexW4205824332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.